Brief: Heidelberg Pharma Q1 Net Loss Widens To 2.4 Million Euros

Heidelberg Pharma AG

12/04/2018 06:09

April 12 (Reuters) - Heidelberg Pharma AG  WL6G.DE :
    * OUTLOOK 2018: INCREASE INVESTMENTS IN PROPRIETARY ATAC
PIPELINE
FOR PREPARATION OF CLINICAL DEVELOPMENT
    * Q1 SALES REVENUE AND INCOME TOTALING EUR 0.7 MILLION
(PREVIOUS
YEAR: EUR 0.6 MILLION)
    * NET LOSS FOR FIRST THREE MONTHS OF FISCAL YEAR INCREASED
TO EUR
2.4 MILLION (PREVIOUS YEAR: EUR 2.0 MILLION)
    * FINANCIAL GUIDANCE REMAINS UNCHANGED COMPARED TO THAT
PROVIDED
ON 22 MARCH 2018
    * Q1 OPERATING EXPENSES INCLUDING DEPRECIATION AND
AMORTIZATION
AMOUNTED TO EUR 3.1 MILLION
    * EXPECTS TO REQUIRE FUNDS OF EUR 13.0 MILLION TO EUR 17.0
MILLION
IN 2018

Source text for Eikon:  ID:nEQwGl1Ra 
Further company coverage:  WL6G.DE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))